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Pathogenesis of Dent’s disease and related syndromes of disorder in 10% to 45% of patients [2, 3] and is most
X-linked nephrolithiasis. Renal stone disease, which affects commonly associated with hypercalciuria [4]. The inheri-
12% of males and 5% of females by the seventh decade, occurs tance of nephrolithiasis and hypercalciuria has been es-as an inherited disorder in 45% of patients and is most com-
tablished to be either autosomal dominant or X-linked inmonly associated with hypercalciuria. The biochemical basis
some families [3–9]. The biochemical basis for hereditaryfor hereditary nephrolithiasis and hypercalciuria is unknown,
and this has therefore been investigated by a “positional clon- nephrolithiasis and hypercalciuria is unknown, and this
ing” approach. As a first step in this approach, the chromosomal has therefore been investigated by a “positional cloning”
locations of two disorders referred to as Dent’s disease and
approach [10]. The first step in this approach is repre-X-linked recessive nephrolithiasis (XRN) were determined.
sented by determining the chromosomal locations of he-These two disorders, which represent unusual forms of the
renal Fanconi syndrome, are characterized by a low molecular reditary nephrolithiasis disorders, and then isolating the
weight proteinuria, hypercalciuria, nephrocalcinosis, nephroli- genes from the critical region. This approach has defined
thiasis and renal failure. An X-linked inheritance for XRN was the molecular basis for four diseases of hereditary neph-established by studies of a North American kindred, and a
rolithiasis: Dent’s disease, X-linked recessive nephroli-similar inheritance for Dent’s disease was indicated by the
thiasis (XRN), X-linked recessive hypophosphatemicobservation of a greater disease severity in males and an ab-
sence of male-to-male transmission in five British families. rickets (XLRH), and the idiopathic low molecular weight
X-linked polymorphic genetic markers were used in linkage proteinuria of Japanese children (JILMWP) [7, 8, 11–14].
studies of these families, and the genes causing Dent’s disease
The positional cloning studies resulted in the identifica-and XRN were mapped to Xp11. In addition, in one family
tion of a voltage-gated chloride channel, CLCN5, genewith Dent’s disease, a microdeletion involving the DNA probe
M27b was identified. This microdeletion was further character- [15]; the progress in these studies will be reviewed.
ized by using yeast artificial chromosomes (YACs) and its size
was estimated to be 515 Kb. A search for renal-expressed genes
from this region identified a novel gene encoding a chloride DENT’S DISEASE AND RELATED SYNDROMES
channel (CLCN5) with similarities to a family of voltage-gated
Four disorders of hereditary hypercalciuric nephroli-chloride channels. Molecular genetic studies of CLCN5 demon-
thiasis (kidney stones), referred to as Dent’s diseasestrated that mutations, which resulted in a functional loss, were
associated with Dent’s disease and XRN. In addition, such [8, 9], XRN [5, 13], XLRH [7], and JILMWP [14], have
CLCN5 mutations that would result in a functional loss have been reported to be due to mutations of the X-linked
also been demonstrated in Japanese children with idiopathic renal specific voltage-gated chloride channel, CLCN5,low molecular weight proteinuria, hypercalciuria and nephro-
gene (Table 1) [11, 12, 16–19]. All four of these diseasescalcinosis, and an Italian kindred with X-linked recessive hypo-
have features in common, and they represent renal tubu-phosphatemic rickets (XLRH) and hypercalciuria. Thus, four
hereditary disorders of nephrolithiasis are due to mutations of lar disorders that are characterized by low molecular
the novel chloride channel, CLCN5. weight proteinuria (LMWP), hypercalciuria, nephrocal-
cinosis, nephrolithiasis and renal failure. In addition,
other renal proximal tubular defects, which include ami-
Renal stone disease (nephrolithiasis and nephrocal- noaciduria, phosphaturia, glycosuria, kaliuresis, uricosu-
cinosis), which affects 12% of males and 5% of females ria and an acquired impairment of urinary acidification,
by the age of 70 years [1, 2], occurs as an inherited may also occur [5, 7, 9, 14]. However, there are differ-
ences between these disorders. For example, rickets has
been a particular feature of Dent’s disease and XLRH,Key words: chloride channel gene, hypercalciuria, low molecular
weight proteinuria, kidney stones. but not XRN or JILMWP, and severe renal failure has
been a feature of Dent’s disease and XRN [5, 7–9, 13,Ó 2000 by the International Society of Nephrology
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Table 1. Mammalian voltage-gated chloride channel (CLC) genes and disease associations
Chloride Chromosomal
channel location Function Tissue distribution Disease association
CLC-1 7q35 Voltage stabilization Skeletal muscle Thomsen’s myotonia, Becker
myotonia, Arrested Devel-
opment of Righting (ADR)
in mouse
CLC-2 3q26-3q28 Cell volume regulation Ubiquitous —
CLC-3 4 ? Multiple —
CLC-4 Xp22.3 ? Muscle, brain, heart —
CLC-5 Xp11.22 Endosomal chloride Kidney (predominantly) Dent’s disease
transport (nephrolithiasis)
CLC-6 1p36 ? Multiple (e.g. brain, —
testes, muscle, kidney)
CLC-7 16p13 ? Multiple (e.g. brain, —
testes, muscle, kidney)
CLC-Ka 1p36 Concentration Kidney Nephrogenic diabetes insipidus
gradient in counter- in mouse
current mechanism
CLC-Kb 1p36 Chloride Kidney Bartter’s syndrome
reabsorption?
Fig. 1. Segregation of Dent’s disease with a microdeletion detected by M27b. Probe M27b, which defines the locus DXS255 and has been localized
to Xp11.22, hybridizes to EcoR1 fragments in the range of 3 to 7 kb in normal individuals, and heterozygosity in females exceeds 90%. Hybridization
of the Southern blot (lower panel) from family 12/89 with probe M27b demonstrated an absence of signals in all the affected males (II.3, II.7,
III.3, III.7 and IV.2) and only one fragment indicating hemizoygosity was detected in the affected females (II.2, II.6, II.9, II.12 and III.2). A control
hybridization of this Southern blot with the probe L1.28, which defines the locus DXS7, yielded signals from all the lanes and demonstrated the
presence of DNA in each lane. Thus, a microdeletion involving M27b is associated with Dent’s disease in family 12/89, and this maps Dent’s
disease to Xp11.22. (Reproduced with permission from Pook et al, Human Molecular Genetics 2:2129–2134, 1993) [8].
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Fig. 2. Deletion mapping in a male patient with Dent’s disease. The DXS255 (M27b) locus was deleted in the patient (II.3, family 12/89, Fig. 1)
with Dent’s disease and a yeast artificial chromosome (YAC) containing DXS255 was isolated. The YAC was 185 kb in size and the telomeric
sequence, L(F1001), which was approximately 50 kb from DXS255, was present, while the centromeric sequence, L(6129), was absent. By using
the centromeric YAC sequence, additional YACs were isolated and their terminal sequences similarly mapped with respect to the deletion. A
YAC contig was established and the size of the microdeletion was revealed to be approximately 515 kb. Use of the 185 kb YAC as a hybridization
probe to screen a renal cDNA library helped to isolate a novel gene, clone RL.3, which encoded a renal chloride channel CLC-5 (Fig. 3).
(Reproduced with permission from Thakker, Acta Nova Leopoldina 302:23–33, 1997 [43]).
14]. Dent’s disease, XRN and XLRH were mapped to amino-butyric acid (GABAA) receptors [25, 26]; (2) the
cystic fibrosis transmembrane conductance regulatorXp11.22 [7, 8, 13], and a microdeletion in one patient
(CFTR) Cl-channel [27]; and (3) the CLCs. The glycinewith Dent’s disease (Fig. 1) facilitated the isolation and
and GABAA receptors, which probably have four trans-characterization (Fig. 2) of a renal chloride channel gene,
membrane domains and may function as pentamers, con-CLCN5 [8, 20, 21]. DNA sequence analyzes have de-
duct chloride ions and are mainly involved in neuronaltected different CLCN5 mutations (Fig. 3), which consist
inhibition. The CFTR, which is a member of the super-of nonsense, missense, splice site, insertional and dele-
family of adenosine 59-triphosphate (ATP)-binding cas-tional mutations, in patients with these four hypercalci-
sette (ABC) transporters and has 12 putative transmem-uric nephrolithiasis disorders [11, 12, 16–19], together
brane domains arranged in two separate blocks withwith another form of a hereditary renal tubular acidosis
two cyclic nucleotide binding domains and a regulatory[22], thereby establishing its causal role in these dis-
region, functions as a cyclic AMP (cAMP)-regulatedeases [23, 24]. Heterologous expression of the wild-type
chloride channel. The CLCs, which are structurally unre-CLCN5 gene or its mutants in Xenopus oocytes also
lated to the other ion channels and form the only knowndemonstrated that the wild-type channel, CLC-5, con-
large family (Table 1) of Cl2 channels, consist of about 12ducted outwardly directed chloride (Cl2) currents that
transmembrane domains [11, 20, 21, 28, 29]. The correctwere either abolished or markedly reduced by the muta-
number and topology of these domains is being estab-tions [11, 12, 16]. The common genetic etiology of
lished, but domain 3 is likely to be a transmembraneCLCN5 mutations and the phenotypic similarities be-
domain [30], and recent studies of domain 4 using cyste-tween all of these syndromes indicated that they were
ine-scanning mutagenesis indicate that domain 4, whichvariants of one disorder, and it has been proposed to
contains a conserved motif that is essential for anionrefer to them collectively as Dent’s disease [12, 16].
selectivity, is likely to be involved in pore formation [31].
The first member, designated CLC-0, was cloned in 1990
VOLTAGE-GATED CHLORIDE CHANNEL from the electric organ of Torpedo marmorata [27], and
(CLC) GENE FAMILY nine different CLCs (CLC-1 to CLC-7, and CLC-Ka
The CLCs represent the most recently discovered of and CLC-Kb; encoded, respectively, by genes CLCN1
the three structurally defined classes of chloride channels to CLCN7, and CLCNKa and CLCNKb) have been
[15]: (1) the extracellular ligand-gated (ELG) receptor identified in mammals [19, 28, 31]. Heterologous expres-
sion in Xenopus oocytes has revealed that the chloridechloride channels, for example, the glycine and gamma-
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channels CLC-0, CLC-1, CLC-2 and CLC-5 conduct a loss of CLC-5 function in the proximal tubule may
chloride currents that are outwardly rectifying and time- lead to a decrease in chloride re-absorption which in
dependent, and with a conductivity sequence that prefers turn results in decreased calcium re-absorption [23, 40].
chloride to iodide [11, 12, 28–34]. These chloride chan- However, this does not explain the abnormal excretion
nels are important for the control of membrane excitabil- of low molecular weight proteins, which are specifically
ity, transepithelial transport and possibly regulation of absorbed in the proximal tubule by endocytosis and
cell volume [29]. CLCs are known to function as transported in an acidic vacuolar-lysosomal system [23,
multimeric complexes, and recent studies have revealed 41]. A loss of chloride channel function in this system
that CLC-0 is a homodimer with two largely independent would prevent the dissipation of the charge that is gener-
pores [33, 34]. The CLC genes are expressed in a variety ated by the electrogenic H12ATPase pump for the pro-
of tissues (Table 1), and only CLCN1, CLCN5 and vision of the acidic environment. However, these possi-
CLCNKb have to date been reported to have disease bilities needed to be explored, and the identification of
associated mutations in humans [15]. Thus, mutations of the specific segments of the human nephron that express
CLCN1 are associated with the myotonia disorders of CLCN5 represented an important step in this pathway
Thomsen and Becker [35–37], mutations of CLCN5 are towards further understanding the role and function of
associated with the hereditary nephrolithiasis disorders CLC-5 in the etiology of hypercalciuria and renal stones.
of Dent’s disease [11, 12, 15], and mutations of CLCNKb These studies, which have detected the expression of
are associated with a form of Bartter’s syndrome [15, 38]. CLC-5 by immunostaining, have revealed that CLC-5
Recent studies of a mouse knockout model for CLCNK1, expression occurs at multiple sites in the human nephron
which is the murine homologue for the human CLCNKa, [42]. Immunohistochemistry studies have revealed that
have demonstrated the occurrence of a form of nephro- CLC-5 expression in the human nephron occurs in the
genic diabetes insipidus (NDI) [39]. This results from a epithelial cells lining the proximal tubules, the medullary
defect in the renal urinary concentrating mechanism and thick ascending limbs of Henle’s loop, and intercalated
reveals an important role for CLCNK1 in the counter-
cells of the collecting ducts. Furthermore, studies of sub-
current multiplication system of the inner medulla [39].
cellular human kidney fractions indicated that CLC-5 isThe human equivalent of this murine model for NDI
likely to be located in recycling endosomes, and thatremains to be identified.
these may form part of the receptor-mediated endocytic
pathway that reabsorbs low molecular weight proteins
ROLE OF CLC-5 IN THE NEPHRON and albumin. Thus, CLC-5 dysfunction in the proximal
tubule may result in low-molecular-weight proteinuriaThe positional cloning [7, 8, 13, 20] and mutational
together with features of the Fanconi syndrome, andanalysis [11, 12, 16] of Dent’s disease and its phenotypic
CLC-5 dysfunction in the thick ascending limb of Henle,variants indicated that CLCN5 encodes a chloride chan-
which is the major site of calcium reabsorption, maynel, CLC-5, whose functional loss results in a generalized
result in hypercalciuria [42].proximal tubular defect, that is, Fanconi syndrome,
which is associated with the hypercalciuria and nephroli-
thiasis of Dent’s disease [23]. However, the mechanisms
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Fig. 3. Schematic representation of a predicted topology of CLC-5. The mutations associated with Dent’s disease, and its phenotypic variants are
illustrated using the reported model [11] for CLC-5 topology. Every 50th amino acid of the 746-amino acid CLC-5 protein and the consensus
phosphorylation (asterisk) and glycosylation (branch) sites at codons 349, 350 and 408, respectively, are indicated. The CLC-5 mutations are shown
with the amino acid highlighted in black and the codon and substituted amino acid shown alongside. Arrows 1 and 2 delineate the amino acids
predicted to be deleted by donor splice site mutations, and arrows 1 to 3 delineate those deleted in a Dent’s disease family with a 2-kb intragenic
deletion. The correct topology for the CLC channels is unknown and the predicted topology of the CLC-5 putative transmembrane domains (D1-
D13) and is based upon a model [11] (inset) that places D4 extracellularly, and in which the hydrophobic core of the D9-D12 region crosses the
membrane three or five times and contains a hydrophilic region (codons 481–502), the precise location of which remains unknown. More recent
studies indicated that D4 is likely to be involved in pore formation [31]. More than 40 CLCN5 mutations have been reported in patients with
Dent’s disease and its phenotypic variants. Such CLCN5 mutations have been demonstrated, by heterologous expression in Xenopus oocytes, to
result in a functional loss of the channel CLC-5 [11, 12, 16].
Thakker: Dent’s disease and X-linked nephrolithiasis792
Reprint requests to Professor R.V. Thakker, Molecular Endocrinol- the CLCN5 gene in Japanese patients with familial idiopathic low-
molecular-weight proteinuria. Kidney Int 52:895–900, 1997ogy Group, Nuffield Department of Clinical Medicine, University of
Oxford, John Radcliffe Hospital, Hedington, Oxford, OX3 904, En- 20. Fisher SE, Black GCM, Lloyd SE, Wrong OM, Thakker RV,
Craig IW: Isolation and partial characterisation of a human chlo-gland, United Kingdom.
E-mail: rajesh.thakker@ndm.ox.ac.uk ride channel gene which is expressed in kidney and is a candidate
for Dent’s disease (an hereditary nephrolithiasis). Hum Mol Genet
3:2053–2059, 1994
REFERENCES 21. Fisher SE, Van Bakel I, Lloyd SE, Pearce SHS, Thakker RV,
Craig IW: Cloning and characterisation of ClC-5, the human kid-1. Consensus Conference: Prevention and treatment of kidney
ney chloride channel gene implicated in Dent’s disease (an X-stones. JAMA 260:977–981, 1988
linked hereditary nephrolithiasis). Genomics 29:598–606, 19952. Smith LH: The medical aspects of urolithiasis: An overview. J Urol
22. Kelleher CL, Buckalew OM, Frederickson ED, Rhodes DJ,141:707–710, 1989
Conner DA, Seidman JG, Seidman CE: CLCN5 mutation Ser244-3. Favus MJ: Familial forms of hypercalciuria. J Urol 141:719–722,
Leu is associated with X-linked renal failure without X-linked1989
recessive hypophosphatemic rickets. Kidney Int 53:31–37, 19984. Coe FL, Parks JH, Asplin JR: The pathogenesis and treatment
23. Wrong OM, Unwin R, Cohen E, Tanner M, Thakker RV: Unrav-of kidney stones. N Engl J Med 327:1141–1152, 1992
elling of the molecular mechanisms of kidney stones. Lancet5. Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber
348:1561–1565, 1996P, Schroeder ET: X-linked recessive nephrolithiasis with renal
24. Scheinman SJ: X-linked hypercalciuric nephrolithiasis: Clinicalfailure. N Engl J Med 325:681–686, 1991
syndromes and chloride channel mutations. Kidney Int 53:3–17,6. Furuse A, Futagoishi Y, Karashima S, Hattori S, Matsuda I:
1998Familial progressive renal tubulopathy. Clin Nephrol 37:192–197,
25. Grenningloh G, Rienitz A, Schmitt B, Methfessel C, Zensen1992
M, Beyreuther K, Gundelfinger D, Betz H: The strychnine-7. Bolino A, Devoto M, Enia G, Zoccali C, Weissenbach J, Romeo
binding sub-unit of the glycine receptor shows homology withG: Genetic mapping in the Xp11.2 region of a new form of X-
nicotinic acetylcholine receptors. Nature 328:215–220, 1987linked hypophosphatemic rickets. Eur J Hum Genet 1:269–279
26. Schofield JR, Darlison MG, Fujita H, Burt DR, Stephenson8. Pook MA, Wrong OM, Wooding C, Norden AGW, Feest TG,
FA, Rodriguez H, Rhee LM, Ramachandran J, Reale V, Glen-Thakker RV: Dent’s disease, a renal Fanconi syndrome with
corse TA, Seeburg PH, Barnard EA: Sequence and functionalnephrocalcinosis and kidney stones, is associated with a micro–
expression of the GABAA receptor shows a ligand-gated receptordeletion involving DXS255 and maps to Xp11. Hum Mol Genet
super-family. Nature 328:221–227, 19872:2129–2134, 1993
27. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R,9. Wrong OM, Norden AGW, Feest TG: Dent’s disease; a familial
Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drummproximal renal tubular syndrome with low-molecular-weight pro-
ML, Ianuzzi MC, Collins FS, Tsui LC: Identification of the cysticteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease,
fibrosis gene: Cloning and characterization of complementaryprogressive renal failure and a marked male predominance. Quart
DNA. Science 245:1066–1073, 1989J Med 87:473–493, 1994
28. Jentsch TJ, Steinmeyer K, Schwarz G: Primary structure of Tor-10. Collins FS: Positional cloning: Let’s not call it reverse any more.
pedo marmorata chloride channel isolated by expression cloningNat Genet 1:3–6, 1992
in Xenopus oocytes. Nature 348:510–514, 199011. Lloyd SE, Pearce SHS, Fisher SE, Steinmeyer K, Schwappach
29. Jentsch TJ, Gunther W, Pusch M, Schwappach B: Properties ofB, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P,
voltage-gated chloride channels of the ClC gene family. J PhysiolRigden SPA, Wrong OM, Jentsch TJ, Craig IW, Thakker RV: A
482:19S–25S, 1990common molecular basis for three inherited kidney stone diseases.
30. Schmidt-Rose T, Jentsch TJ: Transmembrane topology of a CLCNature 379:445–449, 1996
chloride channel. Proc Natl Acad Sci USA 94:7633–7638, 199712. Lloyd SE, Pearce SHS, Gunter W, Kawaguchi H, Igarashi
31. Fahlke C, Yu HT, Beck CL, Rhodes TH, George JRAL: Pore-T, Jentsch TJ, Thakker RV: Idiopathic low molecular weight
forming segments in voltage-gated chloride channels. Natureproteinuria associated with hypercalciuric nephrocalcinosis in Jap-
390:529–532, 1997anese children is due to mutations of the renal chloride channel
32. Brandt S, Jentsch TJ: CL-6 and CLC-7 are two novel broadly(CLCN5). J Clin Invest 99:967–974, 1997
expressed members of the CLC chloride channel family. FEBS13. Scheinman SJ, Pook MA, Wooding C, Pang JT, Frymoyer PA,
Lett 377:15–20, 1995Thakker RV: Mapping the gene causing X-linked recessive neph-
33. Ludewig U, Pusch M, Jentsch TJ: Two physically distinct poresrolithiasis to Xp11.22 by linkage studies. J Clin Invest 91:2351–2357,
in the dimeric CLC-0 chloride channel. Nature 383:340–343, 19961993
34. Middleton RE, Pheasant DJ, Miller C: Homodimeric architec-14. Igarashi T, Hayakawa H, Shiraga H, Kawato H, Yan K, Kawa-
ture of a CLC-type chloride ion channel. Nature 383:337–340, 1996guchi H, Yamanaka T, Tsuchida S, Akagi K: Hypercalciuria
35. Koch MC, Steinmeyer K, Lorenz C, Ricker K, Wolf F, Ottonephrocalcinosis in patients with idiopathic low molecular weight
M, Zoll B, Lehmann-Horn F, Grzeschik K-H, Jentsch TJ: Theproteinuria in Japan: Is this identical to Dent’s disease in the United
skeletal muscle chloride channel in dominant and recessive humanKingdom? Nephron 69:242–247, 1995
15. Thakker RV: Chloride channels cough up. Nat Genet 17:125–127, myotonia. Science 257:797–800, 1992
36. Steinmeyer K, Lorenz C, Pusch M, Koch MC, Jentsch TJ:1997
16. Lloyd SE, Gunter W, Pearce SHS, Thomson A, Bianchi ML, Multimeric structure of CLC-l chloride channel revealed by muta-
tions in dominant myotonia congenita (Thomsen). EMBO JBosio M, Craig IW, Fisher SE, Scheinman SJ, Wrong O, Jentsch
TJ, Thakker RV: Characterisation of renal chloride channel, 13:737–743, 1994
37. Meyer-Kleine C, Steinmeyer K, Ricker K, Jentsch TJ, KochCLCN5, mutations in hypercalciuric nephrolithiasis (kidney
stones) disorders. Human Mol Genet 6:1233–1239, 1977 MC: Spectrum of mutations in the major human skeletal muscle
chloride channel gene (CLCN1) leading to myotonia. Am J Hum17. Akuta N, Lloyd SE, Igarashi T, Shiraga H, Matsuyama T, Yo-
koro S, Cox JPD, Thakker RV: Mutations in CLCN5 in Japanese Genet 57:1325–1334, 1995
38. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Men-children with idiopathic low molecular weight proteinuria, hyper-
calciuria and nephrocalcinosis. Kidney Int 52:911–916, 1997 donca E, Stone R, Shurman S, Nayir A, Alpay H, Aysin B,
Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM,18. Oudet C, Martin-Coignard D, Pannetier S, Praud E, Champion
G, Hanauer A: A second family with XLRH displays the mutation Pilz D, Brem A, Trachtman H, Griswold W, Richard GA,
Johne Lifton RP: Mutations in the chloride channel gene,S244L in the CLCN5 gene. Hum Genet 99:781–784, 1997
19. Nakazato H, Hattori S, Furuse A, Kawano T, Karashima S, CLCNKB, cause Bartter’s syndrome type III. Nat Genet 17:171–
178, 1997Tsuruta M, Yoshimutao T, Endo F, Matsuda I: Mutations in
Thakker: Dent’s disease and X-linked nephrolithiasis 793
39. Uchida S: CLC chloride channels in the kidney. Basic science 42. Devuyst O, Christie PT, Courtoy PJ, Beauwens R, Thakker
RV: Intra-renal and subcellular distribution of the human chloridesymposium. J Am Soc Nephrol 9:1–127, 1998
40. Hebert SC: Crystal clear chloride channels. Nature 379:398–399, channel, CLC-5, reveals a pathophysiological basis for Dent’s dis-
ease. Hum Mol Genet (in press)1996
41. Christensen E, Nielsen S: Structural and functional features of 43. Thakker RV: Renal chloride channel, CLCN5, mutations and
hypercalciuric neprolithiasis disorders. Acta Nova Leopoldina Nrprotein handling in the kidney proximal tubule. Semin Nephrol
11:414–439, 1991 302:23–33, 1997
